1
|
Yang B, Deng X, Qu X, Li Y, Guo L, Yu N. Identification of functional near-infrared spectroscopy for older adults with mild cognitive impairment: a systematic review. Front Aging Neurosci 2025; 17:1492800. [PMID: 40271185 PMCID: PMC12014625 DOI: 10.3389/fnagi.2025.1492800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2024] [Accepted: 03/13/2025] [Indexed: 04/25/2025] Open
Abstract
Objective Mild cognitive impairment (MCI), a common state of cognitive impairment without significant impairment in daily functioning among older adults, is mainly identified using various neuropsychological tests, clinical interviews, and collateral history with some subjective interferences. This systematic review aimed to investigate the functional near-infrared spectroscopy (fNIRS) features of older adults with MCI compared with those with normal cognitive function to assist in the diagnosis of MCI. Methods A literature search was conducted in electronic databases, including PubMed, Web of Science, Embase, and Cochrane Library, up to June 15, 2024. The data on article information (first author and year of publication), participant characteristics, task paradigms, regions of interest (ROIs), fNIRS device attributes, and results related to cerebral oxygenation and hemodynamics were extracted. Results Finally, 34 relevant studies were identified, involving 1033 patients with MCI and 1107 age-, sex-, and education-matched controls with normal cognitive function. We found that the studies frequently used working memory-related task paradigms and resting-state measurements. Also, the prefrontal cortex was a primary ROI, and the changes in oxygenated hemoglobin concentration were the most basic research attributes used to derive measures such as functional connectivity (FC), FC variability, slope, and other parameters. However, ROI activation levels differed inconsistently between patients with MCI and individuals with normal cognition across studies. In general, the activation levels in the ROI of MCI patients may be higher than, lower than, or comparable to those in the normal control group. Conclusion Research on fNIRS in elderly patients with MCI aims to provide an objective marker for MCI diagnosis. The current findings are mixed. However, these differences can be partly explained with the theoretical support from the interaction of cognitive load theory and scaffolding theory of aging and cognition, taking into account factors such as unspecified MCI subtypes, task difficulty, task design, monitoring duration, and population characteristics. Therefore, future studies should consider definite MCI subtypes, strict and well-designed paradigms, long-term monitoring, and large sample sizes to obtain the most consistent results, thereby providing objective references for the clinical diagnosis of MCI in elderly patients.
Collapse
Affiliation(s)
- Bo Yang
- Department of Center for Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
| | - Xia Deng
- Department of Center for Psychosomatic Medicine, Sichuan Provincial Center for Mental Health, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
| | - Xianfeng Qu
- Department of Radiology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
| | - Yingjie Li
- Department of Neurology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
| | - Lei Guo
- Department of Neurology, Xindu District People’s Hospital of Chengdu, Chengdu, China
| | - Nengwei Yu
- Department of Neurology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, China
| |
Collapse
|
2
|
Wang S, Wang W, Chen J, Yu X. Alterations in brain functional connectivity in patients with mild cognitive impairment: A systematic review and meta-analysis of functional near-infrared spectroscopy studies. Brain Behav 2024; 14:e3414. [PMID: 38616330 PMCID: PMC11016629 DOI: 10.1002/brb3.3414] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Revised: 01/09/2024] [Accepted: 01/10/2024] [Indexed: 04/16/2024] Open
Abstract
Emerging evidences suggest that cognitive deficits in individuals with mild cognitive impairment (MCI) are associated with disruptions in brain functional connectivity (FC). This systematic review and meta-analysis aimed to comprehensively evaluate alterations in FC between MCI individuals and healthy control (HC) using functional near-infrared spectroscopy (fNIRS). Thirteen studies were included in qualitative analysis, with two studies synthesized for quantitative meta-analysis. Overall, MCI patients exhibited reduced resting-state FC, predominantly in the prefrontal, parietal, and occipital cortex. Meta-analysis of two studies revealed a significant reduction in resting-state FC from the right prefrontal to right occipital cortex (standardized mean difference [SMD] = -.56; p < .001), left prefrontal to left occipital cortex (SMD = -.68; p < .001), and right prefrontal to left occipital cortex (SMD = -.53; p < .001) in MCI patients compared to HC. During naming animal-walking task, MCI patients exhibited enhanced FC in the prefrontal, motor, and occipital cortex, whereas a decrease in FC was observed in the right prefrontal to left prefrontal cortex during calculating-walking task. In working memory tasks, MCI predominantly showed increased FC in the medial and left prefrontal cortex. However, a decreased in prefrontal FC and a shifted in distribution from the left to the right prefrontal cortex were noted in MCI patients during a verbal frequency task. In conclusion, fNIRS effectively identified abnormalities in FC between MCI and HC, indicating disrupted FC as potential markers for the early detection of MCI. Future studies should investigate the use of task- and region-specific FC alterations as a sensitive biomarker for MCI.
Collapse
Affiliation(s)
- Shuangyan Wang
- Department of Geriatric Neurology, Guangzhou First People's HospitalThe Second Affiliated Hospital of South China University of TechnologyGuangzhouGuangdongChina
| | - Weijia Wang
- Department of LibrarySun Yat‐sen UniversityGuangzhouGuangdongChina
| | - Jinglong Chen
- Department of Geriatric Neurology, Guangzhou First People's HospitalThe Second Affiliated Hospital of South China University of TechnologyGuangzhouGuangdongChina
| | - Xiaoqi Yu
- Department of Geriatric Neurology, Guangzhou First People's HospitalThe Second Affiliated Hospital of South China University of TechnologyGuangzhouGuangdongChina
| |
Collapse
|
3
|
Srinivasan S, Butters E, Collins-Jones L, Su L, O’Brien J, Bale G. Illuminating neurodegeneration: a future perspective on near-infrared spectroscopy in dementia research. NEUROPHOTONICS 2023; 10:023514. [PMID: 36788803 PMCID: PMC9917719 DOI: 10.1117/1.nph.10.2.023514] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/27/2022] [Accepted: 01/13/2023] [Indexed: 06/18/2023]
Abstract
SIGNIFICANCE Dementia presents a global healthcare crisis, and neuroimaging is the main method for developing effective diagnoses and treatments. Yet currently, there is a lack of sensitive, portable, and low-cost neuroimaging tools. As dementia is associated with vascular and metabolic dysfunction, near-infrared spectroscopy (NIRS) has the potential to fill this gap. AIM This future perspective aims to briefly review the use of NIRS in dementia to date and identify the challenges involved in realizing the full impact of NIRS for dementia research, including device development, study design, and data analysis approaches. APPROACH We briefly appraised the current literature to assess the challenges, giving a critical analysis of the methods used. To assess the sensitivity of different NIRS device configurations to the brain with atrophy (as is common in most forms of dementia), we performed an optical modeling analysis to compare their cortical sensitivity. RESULTS The first NIRS dementia study was published in 1996, and the number of studies has increased over time. In general, these studies identified diminished hemodynamic responses in the frontal lobe and altered functional connectivity in dementia. Our analysis showed that traditional (low-density) NIRS arrays are sensitive to the brain with atrophy (although we see a mean decrease of 22% in the relative brain sensitivity with respect to the healthy brain), but there is a significant improvement (a factor of 50 sensitivity increase) with high-density arrays. CONCLUSIONS NIRS has a bright future in dementia research. Advances in technology - high-density devices and intelligent data analysis-will allow new, naturalistic task designs that may have more clinical relevance and increased reproducibility for longitudinal studies. The portable and low-cost nature of NIRS provides the potential for use in clinical and screening tests.
Collapse
Affiliation(s)
- Sruthi Srinivasan
- University of Cambridge, Department of Engineering, Electrical Engineering, Cambridge, United Kingdom
| | - Emilia Butters
- University of Cambridge, Department of Engineering, Electrical Engineering, Cambridge, United Kingdom
- University of Cambridge, Department of Psychiatry, Cambridge, United Kingdom
| | - Liam Collins-Jones
- University College London, Department of Medical Physics, London, United Kingdom
| | - Li Su
- University of Cambridge, Department of Psychiatry, Cambridge, United Kingdom
- University of Sheffield, Department of Neuroscience, Sheffield, United Kingdom
| | - John O’Brien
- University of Cambridge, Department of Psychiatry, Cambridge, United Kingdom
| | - Gemma Bale
- University of Cambridge, Department of Engineering, Electrical Engineering, Cambridge, United Kingdom
- University of Cambridge, Department of Physics, Cambridge, United Kingdom
| |
Collapse
|
4
|
Grässler B, Herold F, Dordevic M, Gujar TA, Darius S, Böckelmann I, Müller NG, Hökelmann A. Multimodal measurement approach to identify individuals with mild cognitive impairment: study protocol for a cross-sectional trial. BMJ Open 2021; 11:e046879. [PMID: 34035103 PMCID: PMC8154928 DOI: 10.1136/bmjopen-2020-046879] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/11/2020] [Accepted: 05/11/2021] [Indexed: 12/26/2022] Open
Abstract
INTRODUCTION The diagnosis of mild cognitive impairment (MCI), that is, the transitory phase between normal age-related cognitive decline and dementia, remains a challenging task. It was observed that a multimodal approach (simultaneous analysis of several complementary modalities) can improve the classification accuracy. We will combine three noninvasive measurement modalities: functional near-infrared spectroscopy (fNIRS), electroencephalography and heart rate variability via ECG. Our aim is to explore neurophysiological correlates of cognitive performance and whether our multimodal approach can aid in early identification of individuals with MCI. METHODS AND ANALYSIS This study will be a cross-sectional with patients with MCI and healthy controls (HC). The neurophysiological signals will be measured during rest and while performing cognitive tasks: (1) Stroop, (2) N-back and (3) verbal fluency test (VFT). Main aims of statistical analysis are to (1) determine the differences in neurophysiological responses of HC and MCI, (2) investigate relationships between measures of cognitive performance and neurophysiological responses and (3) investigate whether the classification accuracy can be improved by using our multimodal approach. To meet these targets, statistical analysis will include machine learning approaches.This is, to the best of our knowledge, the first study that applies simultaneously these three modalities in MCI and HC. We hypothesise that the multimodal approach improves the classification accuracy between HC and MCI as compared with a unimodal approach. If our hypothesis is verified, this study paves the way for additional research on multimodal approaches for dementia research and fosters the exploration of new biomarkers for an early detection of nonphysiological age-related cognitive decline. ETHICS AND DISSEMINATION Ethics approval was obtained from the local Ethics Committee (reference: 83/19). Data will be shared with the scientific community no more than 1 year following completion of study and data assembly. TRIAL REGISTRATION NUMBER ClinicalTrials.gov, NCT04427436, registered on 10 June 2020, https://clinicaltrials.gov/ct2/show/study/NCT04427436.
Collapse
Affiliation(s)
- Bernhard Grässler
- Institute of Sport Science, Faculty of Humanities, Otto von Guericke University Magdeburg, Magdeburg, Germany
| | - Fabian Herold
- Department of Neuroprotection, German Centre for Neurodegenerative Diseases Site Magdeburg, Magdeburg, Germany
| | - Milos Dordevic
- Department of Neuroprotection, German Centre for Neurodegenerative Diseases Site Magdeburg, Magdeburg, Germany
| | - Tariq Ali Gujar
- Institute of Sport Science, Faculty of Humanities, Otto von Guericke University Magdeburg, Magdeburg, Germany
| | - Sabine Darius
- Occupational Medicine, Otto von Guericke University Medical Faculty, Magdeburg, Germany
| | - Irina Böckelmann
- Occupational Medicine, Otto von Guericke University Medical Faculty, Magdeburg, Germany
| | - Notger G Müller
- Department of Neuroprotection, German Centre for Neurodegenerative Diseases Site Magdeburg, Magdeburg, Germany
- Department of Neurology, Otto von Guericke University Medical Faculty, Magdeburg, Germany
| | - Anita Hökelmann
- Institute of Sport Science, Faculty of Humanities, Otto von Guericke University Magdeburg, Magdeburg, Germany
| |
Collapse
|
5
|
Chen WL, Wagner J, Heugel N, Sugar J, Lee YW, Conant L, Malloy M, Heffernan J, Quirk B, Zinos A, Beardsley SA, Prost R, Whelan HT. Functional Near-Infrared Spectroscopy and Its Clinical Application in the Field of Neuroscience: Advances and Future Directions. Front Neurosci 2020; 14:724. [PMID: 32742257 PMCID: PMC7364176 DOI: 10.3389/fnins.2020.00724] [Citation(s) in RCA: 161] [Impact Index Per Article: 32.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2020] [Accepted: 06/17/2020] [Indexed: 01/20/2023] Open
Abstract
Similar to functional magnetic resonance imaging (fMRI), functional near-infrared spectroscopy (fNIRS) detects the changes of hemoglobin species inside the brain, but via differences in optical absorption. Within the near-infrared spectrum, light can penetrate biological tissues and be absorbed by chromophores, such as oxyhemoglobin and deoxyhemoglobin. What makes fNIRS more advantageous is its portability and potential for long-term monitoring. This paper reviews the basic mechanisms of fNIRS and its current clinical applications, the limitations toward more widespread clinical usage of fNIRS, and current efforts to improve the temporal and spatial resolution of fNIRS toward robust clinical usage within subjects. Oligochannel fNIRS is adequate for estimating global cerebral function and it has become an important tool in the critical care setting for evaluating cerebral oxygenation and autoregulation in patients with stroke and traumatic brain injury. When it comes to a more sophisticated utilization, spatial and temporal resolution becomes critical. Multichannel NIRS has improved the spatial resolution of fNIRS for brain mapping in certain task modalities, such as language mapping. However, averaging and group analysis are currently required, limiting its clinical use for monitoring and real-time event detection in individual subjects. Advances in signal processing have moved fNIRS toward individual clinical use for detecting certain types of seizures, assessing autonomic function and cortical spreading depression. However, its lack of accuracy and precision has been the major obstacle toward more sophisticated clinical use of fNIRS. The use of high-density whole head optode arrays, precise sensor locations relative to the head, anatomical co-registration, short-distance channels, and multi-dimensional signal processing can be combined to improve the sensitivity of fNIRS and increase its use as a wide-spread clinical tool for the robust assessment of brain function.
Collapse
Affiliation(s)
- Wei-Liang Chen
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States.,Department of Neurology, Children's Hospital of Wisconsin, Milwaukee, WI, United States.,School of Medicine, University of Washington, Seattle, WA, United States
| | - Julie Wagner
- Department of Biochemical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, United States
| | - Nicholas Heugel
- Department of Biochemical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, United States
| | - Jeffrey Sugar
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States
| | - Yu-Wen Lee
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States.,Department of Neurology, Children's Hospital of Wisconsin, Milwaukee, WI, United States
| | - Lisa Conant
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States
| | - Marsha Malloy
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States.,Department of Neurology, Children's Hospital of Wisconsin, Milwaukee, WI, United States
| | - Joseph Heffernan
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States
| | - Brendan Quirk
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States
| | - Anthony Zinos
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States.,Department of Biochemical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, United States
| | - Scott A Beardsley
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States.,Department of Biochemical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, WI, United States
| | - Robert Prost
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States
| | - Harry T Whelan
- Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, United States.,Department of Neurology, Children's Hospital of Wisconsin, Milwaukee, WI, United States
| |
Collapse
|